Author pages are created from data sourced from our academic publisher partnerships and public sources.
372 COMBINED ORAL THERAPY WITH TADALAFIL AND ALFUZOSIN IN PATIENTS WITH LOWER URINARY TRACT SYMPTOMS AND ERECTILE DYSFUNCTION
HEPATITIS B VARIANT IN EUROPE
Hepatitis C virus infection and alanine transaminase levels in the general population: a survey in a southern Italian town.
BACKGROUND/AIM The aim of the study was to estimate the prevalence, risk factors and genotype distribution of hepatitis C virus (HCV) in the general population older than 5 years of age in a southern… Expand
Physical activity and PDE5 inhibitors in the treatment of erectile dysfunction: results of a randomized controlled study.
INTRODUCTION Physical activity (PhA) has proven to be a protective factor for normal erectile function in numerous epidemiological studies. AIM The aim of this study was to establish if PhA could… Expand
Efficacy and safety of combined oral therapy with tadalafil and alfuzosin: an integrated approach to the management of patients with lower urinary tract symptoms and erectile dysfunction. Preliminary…
- G. Liguori, C. Trombetta, +7 authors E. Belgrano
- The journal of sexual medicine
- 1 February 2009
INTRODUCTION Alpha1-blockers (AB) are the first-line monotherapy for lower urinary tract symptoms (LUTS). Phosphodiesterase type 5 (PDE5) inhibitors are the first-line treatment for erectile… Expand
Effectiveness of a multi-disciplinary standardized management model in the treatment of chronic hepatitis C in drug addicts engaged in detoxification programmes.
AIM To evaluate the effect of a multi-disciplinary standardized management model on the efficacy of pegylated (Peg)-interferon alpha-2b plus ribavirin treatment of chronic hepatitis C in drug addicts… Expand
Mild pancreatic damage in acute viral hepatitis.
Whether and to what extent the pancreas is involved in acute viral hepatitis is still unclear. In order to address this issue we evaluated serum and urinary amylase and isoamylase levels in 92… Expand
SERUM LEVELS OF HEPATITIS B SURFACE AND CORE ANTIGENS DURING IMMUNOSUPPRESSIVE TREATMENT OF HBsAg-POSITIVE CHRONIC ACTIVE HEPATITIS
One of the following treatments was randomly assigned to 101 consecutive patients with biopsy-proven chronic active hepatitis: prednisone 20 mg daily, azathioprine 100 mg daily, prednisone 20 mg and… Expand
Investigation of intestine function during acute viral hepatitis using combined sugar oral loads.
One fifth of all cases of A virus hepatitis (AVH) have symptoms of gastroenteritis at the onset. This study investigated the mediated intestinal absorption of D-xylose (D-xyl) and… Expand
Effect of Immunosuppressive Therapy on HBsAg‐Positive Chronic Active Hepatitis in Relation to Presence or Absence of HBeAg and Anti‐HBe
Two hundred and four patients with biopsy‐proven HBsAg‐positive chronic active hepatitis were treated for at least 2 years with azathioprine, prednisolone or a combination of both, or were untreated.… Expand